Northeast Financial Consultants’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,105
| Closed | -$109K | – | 397 |
|
|
2021
Q4 | $109K | Hold |
10,105
| – | – | 0.01% | 346 |
|
|
2021
Q3 | $117K | Buy |
+10,105
| New | +$117K | 0.01% | 345 |
|
|
2020
Q2 | – | Sell |
-1,937
| Closed | -$18K | – | 301 |
|
|
2020
Q1 | $18K | Hold |
1,937
| – | – | ﹤0.01% | 270 |
|
|
2019
Q4 | $26K | Hold |
1,937
| – | – | ﹤0.01% | 304 |
|
|
2019
Q3 | $17K | Hold |
1,937
| – | – | ﹤0.01% | 322 |
|
|
2019
Q2 | $28K | Buy |
+1,937
| New | +$28K | ﹤0.01% | 326 |
|